FR2812197B1 - Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches - Google Patents

Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches

Info

Publication number
FR2812197B1
FR2812197B1 FR0009881A FR0009881A FR2812197B1 FR 2812197 B1 FR2812197 B1 FR 2812197B1 FR 0009881 A FR0009881 A FR 0009881A FR 0009881 A FR0009881 A FR 0009881A FR 2812197 B1 FR2812197 B1 FR 2812197B1
Authority
FR
France
Prior art keywords
bronchia
inflammation
treatment
upper airways
airways
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0009881A
Other languages
English (en)
Other versions
FR2812197A1 (fr
Inventor
Marc Lemaire
Laurent Lecourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Liquide Sante International SA
Original Assignee
Air Liquide Sante International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Sante International SA filed Critical Air Liquide Sante International SA
Priority to FR0009881A priority Critical patent/FR2812197B1/fr
Priority to AU2001278558A priority patent/AU2001278558A1/en
Priority to EP01956632A priority patent/EP1307208A1/fr
Priority to PCT/FR2001/002396 priority patent/WO2002009731A1/fr
Publication of FR2812197A1 publication Critical patent/FR2812197A1/fr
Application granted granted Critical
Publication of FR2812197B1 publication Critical patent/FR2812197B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
FR0009881A 2000-07-27 2000-07-27 Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches Expired - Fee Related FR2812197B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0009881A FR2812197B1 (fr) 2000-07-27 2000-07-27 Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
AU2001278558A AU2001278558A1 (en) 2000-07-27 2001-07-23 Use of co for treating inflammation of upper airways or bronchi
EP01956632A EP1307208A1 (fr) 2000-07-27 2001-07-23 Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
PCT/FR2001/002396 WO2002009731A1 (fr) 2000-07-27 2001-07-23 Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0009881A FR2812197B1 (fr) 2000-07-27 2000-07-27 Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches

Publications (2)

Publication Number Publication Date
FR2812197A1 FR2812197A1 (fr) 2002-02-01
FR2812197B1 true FR2812197B1 (fr) 2003-01-03

Family

ID=8852996

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0009881A Expired - Fee Related FR2812197B1 (fr) 2000-07-27 2000-07-27 Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches

Country Status (4)

Country Link
EP (1) EP1307208A1 (fr)
AU (1) AU2001278558A1 (fr)
FR (1) FR2812197B1 (fr)
WO (1) WO2002009731A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
EP1404811B1 (fr) 2001-06-21 2008-11-12 Beth Israel Deaconess Medical Center, Inc. Le monoxyde de carbone ameliore les resultats dans des transplantations de tissus et d'organes et supprime l'apoptose
CN100393323C (zh) 2002-02-13 2008-06-11 贝思·伊斯雷尔·迪科尼斯医药中心 治疗血管疾病的方法
JP4585765B2 (ja) 2002-04-15 2010-11-24 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 壊死性腸炎の治療方法
AU2003226366A1 (en) 2002-04-15 2003-11-03 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
WO2003088923A2 (fr) 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Procedes relatifs au traitement de l'occlusion intestinale
WO2003096977A2 (fr) 2002-05-17 2003-11-27 Yale University Methodes de traitement de l'hepatite
ATE420650T1 (de) * 2002-06-12 2009-01-15 Air Liquide Deutschland Gmbh Cerebrale protektion mit einem xenonhaltigen gas
WO2003105872A1 (fr) * 2002-06-12 2003-12-24 Messer Griesheim Gmbh Spasmolytique a base de xenon
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
JP2006514621A (ja) * 2002-11-07 2006-05-11 ユニバーシティー オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 出血性ショックの治療
FR2849779B1 (fr) 2003-01-15 2006-07-14 Air Liquide Sante Sa Utilisation de xenon ou de n2o dans le traitement des deteriorations cellulaires cerebrales post-ischemiques
CA2542412A1 (fr) * 2003-10-21 2005-05-06 Aga Ab Emploi du xenon pour contrer la mort programmee des cellules
EP1552840A1 (fr) * 2004-01-07 2005-07-13 Aga Ab Mélange de xénon et de monoxyde de carbone pour la protection de cellules
DK1962869T3 (da) * 2005-12-21 2013-06-24 Solaeromed Inc Behandling af luftvejssygdomme
FR2956323B1 (fr) * 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) * 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037644A1 (fr) * 1996-04-05 1997-10-16 The General Hospital Corporation Traitement d'un type d'hemoglobinose
JP2000517311A (ja) * 1996-08-27 2000-12-26 メッサー グリースハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング 水素含有薬剤

Also Published As

Publication number Publication date
FR2812197A1 (fr) 2002-02-01
WO2002009731A1 (fr) 2002-02-07
EP1307208A1 (fr) 2003-05-07
AU2001278558A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
FR15C0030I2 (fr) Composes d'acide benzoique 1,2,4-oxadiazole et utilisation de ceux-ci dans la suppression non-sens et le traitement de maladies
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
EE200200286A (et) Uued aminopropüülfosfiinhapped ning nende kasutamine
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
ID24963A (id) Celana dalam yang dapat dibuang setelah sekali pemakaian
FR2809005B1 (fr) Utilisation du manganese dans le traitement des rides
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EE200300474A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
NO20033443L (no) Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser
ITTO20001156A0 (it) Apparecchiatura per il trattamento di disgregazione di campioni biologici e dispositivo disgregatore per l'impiego in detta apparecchiatura.
NO20040659L (no) Isoksazolopyridinoner og andvendelse derav ved behandling av Parkinsons sykdom
FR2839254B1 (fr) Valet d'aide pour l'habillage ou le deshabillage notamment des personnes souffrant d'un handicape et vetement associe
ID29494A (id) Pengatasan dalam atau kaitannya terhadap pengurangan bau
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
FR2786096B1 (fr) Composition pour la prevention et le traitement topique de la cellulite
NO20024746L (no) Anvendelse av galantamin ved behandling av nevropsykiatrisk oppförsel assosiert med Alzheimers sykdom
FR2826269B1 (fr) Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee
EP1322778A4 (fr) Utilisation de cyr61 dans le traitement et le diagnostic des leiomyomes uterins chez la femme
GB9904081D0 (en) Improvements in or relating to the treatment or prevention of parasitic infestation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080331